Aurinia Pharmaceuticals's total assets for Q3 2025 were $527.53M, an increase of 4.97% from the previous quarter. AUPH total liabilities were $161.76M for the fiscal quarter, a -3.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.